Improvement in Plasma Drug Activity during the Early Treatment Interval among Tanzanian Patients with Multidrug-Resistant Tuberculosis

• Norah D. Ndusilo,

  Affiliation Kilimanjaro Clinical Research Institute, Moshi, Tanzania

  ⨯
• Scott K. Heysell ,

  * E-mail: skh8r@virginia.edu

  Affiliations Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, United States of America, Kibong’oto Infectious Diseases Hospital, Sanya Juu, Tanzania

  ⨯
• Stellah G. Mpagama,

  Affiliations Kilimanjaro Clinical Research Institute, Moshi, Tanzania, Kibong’oto Infectious Diseases Hospital, Sanya Juu, Tanzania

  ⨯
• Jean Gratz,

  Affiliations Kilimanjaro Clinical Research Institute, Moshi, Tanzania, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, United States of America

  ⨯
• Farida H. Segesela,

  Affiliation Kilimanjaro Clinical Research Institute, Moshi, Tanzania

  ⨯
• Saumu J. Pazia,

  Affiliation Kilimanjaro Clinical Research Institute, Moshi, Tanzania

  ⨯
• Xin-Qun Wang,

  Affiliation Department of Public Health Sciences, University of Virginia, Charlottesville, United States of America

  ⨯
• Eric R. Houpt,

  Affiliation Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, United States of America

  ⨯
• Gibson S. Kibiki

  Affiliation Kilimanjaro Clinical Research Institute, Moshi, Tanzania

  ⨯